THE SWISS HIV COHORT STUDY - RATIONALE, ORGANIZATION AND SELECTED BASE-LINE CHARACTERISTICS

被引:147
|
作者
LEDERGERBER, B [1 ]
VONOVERBECK, J [1 ]
EGGER, M [1 ]
LUTHY, R [1 ]
BUCHER, H [1 ]
ERB, P [1 ]
MATTER, L [1 ]
PICHLER, WJ [1 ]
HIRSCHEL, B [1 ]
PERRIN, L [1 ]
FRANCIOLI, P [1 ]
FREI, P [1 ]
FIERZ, W [1 ]
VERNAZZA, P [1 ]
GROB, PJ [1 ]
GUTZWILLER, F [1 ]
HEUSSER, R [1 ]
KNOPFLI, D [1 ]
BUNDSCHU, B [1 ]
HACHLER, I [1 ]
MEISTER, T [1 ]
机构
[1] UNIV ZURICH HOSP, DEPT MED, DIV INFECT DIS, CH-8091 ZURICH, SWITZERLAND
来源
SOZIAL-UND PRAVENTIVMEDIZIN | 1994年 / 39卷 / 06期
关键词
D O I
10.1007/BF01299670
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objectives: This paper describes the rationale and design features of the Swiss HIV Cohort Study (SHCS) and the baseline characteristics of participants enrolled up to March 31st 1993. The objectives include epidemiological, clinical and laboratory research. Design: The SHCS is a prospective cohort study of HIV infected adolescents and adults seen at the outpatient clinics of the Swiss University Hospitals in Basle, Berne, Geneva, Lausanne and Zurich and the Cantonal Hospital St. Gall. The multicentre collaboration was initiated in September 1988 by the Swiss Federal Office of Public Health. Data collected prior to this date by several participating centers using a similar protocol were included, the earliest records dating back to 1982. Follow-up visits are scheduled every 6 months. Enrollment: As of March 31st 1993, 6253 participants (M: 4580, F: 1675) were included with a total of 16015 person-years of follow-up (mean 2.6 years). HIV transmission categories were 44%,intravenous drug users (IDU) 32% men who had sex with men (MSM) 18% heterosexual contacts (HET) and 4% other The proportion of MSM among male participants decreased from 62% in 1385 to 40% in 1987, to remain stable thereafter: The proportion of IDU among males was around 40% throughout, whereas in females, there was a pronounced decline from 90% IDU in 1985 to 50% in 1992. Conversely there was a striking increase in registrations of women presumably infected by HET from 8% in 1985 to 50% in 1932. Among men, the proportion classified as HET increased from 2% to 15%. It is estimated, that a large proportion of all Swiss AIDS patients (70%) and HIV infected individuals (32%-47%) are enrolled in the Swiss HIV Cohort Study Losses to follow-up, however are common. Conclusions: The SHCS serves multiple purposes as a research project, as infrastructure for multidisciplinary research and as a tool to improve patient care. Several international and national trials, post-marketing surveillances and expanded access protocols were or still are based upon its infrastructure. The large number of female participants and of participants AIDS-free at entry make the database especially valuable.
引用
收藏
页码:387 / 394
页数:8
相关论文
共 50 条
  • [41] BASE-LINE STUDY FOR THE EVALUATION OF THE MENTAL-HEALTH PROGRAM
    SCHULSINGER, F
    ACTA PSYCHIATRICA SCANDINAVICA, 1991, 83 : 55 - 58
  • [42] Hodgkin lymphoma in the Swiss HIV Cohort Study
    Clifford, Gary M.
    Rickenbach, Martin
    Lise, Mauro
    Dal Maso, Luigino
    Battegay, Manuel
    Bohlius, Julia
    El Amari, Emmanuelle Boffi
    Karrer, Urs
    Jundt, Gernot
    Bordoni, Andrea
    Ess, Silvia
    Franceschi, Silvia
    BLOOD, 2009, 113 (23) : 5737 - 5742
  • [43] MEASURING PROGRESS IN APHASIA THERAPY - A MULTIPLE BASE-LINE STUDY
    HESKETH, A
    BRITISH JOURNAL OF DISORDERS OF COMMUNICATION, 1986, 21 (01): : 47 - 62
  • [44] CLINICAL HETEROGENEITY REVISITED - BASE-LINE FINDINGS OF THE PREDICTORS STUDY
    STERN, Y
    RICHARDS, M
    FOLSTEIN, M
    ALBERT, M
    MILLER, L
    BYLSMA, F
    LAFLECHE, G
    MARDER, K
    BELL, K
    SANO, M
    DEVANAND, D
    LORECK, D
    WOOTTON, J
    JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY, 1993, 15 (01) : 57 - 58
  • [45] Rilpivirine use in the Swiss HIV cohort study: a prospective cohort study
    Delphine Sculier
    Angèle Gayet-Ageron
    Manuel Battegay
    Matthias Cavassini
    Jan Fehr
    Cedric Hirzel
    Patrick Schmid
    Enos Bernasconi
    Alexandra Calmy
    BMC Infectious Diseases, 17
  • [46] THE ADVANCED GLAUCOMA INTERVENTION STUDY (AGIS) .1. STUDY DESIGN AND METHODS AND BASE-LINE CHARACTERISTICS OF STUDY PATIENTS
    BROWN, RH
    LYNCH, M
    LEEF, D
    GUNSBY, J
    LOBER, K
    MOORE, K
    STEPKA, C
    VELATHOMAS, A
    GAASTERLAND, DE
    COYLE, E
    HUNDLEY, M
    ASHBURN, F
    VAYER, L
    MICHELITSCH, K
    LAUBER, S
    BURT, E
    RAE, A
    WEBER, PA
    DERICK, R
    MCKINNEY, K
    MOORE, D
    BAKER, ND
    KAPETANSKY, F
    LEHMAN, D
    GLOECKNER, B
    SHARF, LJ
    ROMANS, B
    SATTERWHITE, Y
    SIMMONS, L
    HARBIN, TS
    OZMENT, RR
    WRIGHT, J
    BUTLER, L
    LASALLE, J
    PERRY, M
    NUMMERDOR, D
    WILLE, L
    ECKEL, A
    SESSION, C
    MARTIN, A
    CYRLIN, MN
    FAZIO, R
    WILENSKY, JT
    LINDENMUTH, K
    NAIL, CA
    RATHBONE, D
    GATES, V
    TADELMAN, M
    SONTY, S
    HOPKINS, G
    CONTROLLED CLINICAL TRIALS, 1994, 15 (04): : 299 - 325
  • [47] HEMOPHILIA GROWTH AND DEVELOPMENT STUDY - BASE-LINE NEURODEVELOPMENTAL FINDINGS
    LOVELAND, KA
    STEHBENS, J
    CONTANT, C
    BORDEAUX, JD
    SIROIS, P
    BELL, TS
    HILL, S
    SCOTT, A
    BOWMAN, M
    SCHILLER, M
    WATKINS, J
    OLSON, R
    MOYLAN, P
    COOL, V
    BELDEN, B
    JOURNAL OF PEDIATRIC PSYCHOLOGY, 1994, 19 (02) : 223 - 239
  • [48] Rilpivirine use in the Swiss HIV cohort study: a prospective cohort study
    Sculier, Delphine
    Gayet-Ageron, Angele
    Battegay, Manuel
    Cavassini, Matthias
    Fehr, Jan
    Hirzel, Cedric
    Schmid, Patrick
    Bernasconi, Enos
    Calmy, Alexandra
    BMC INFECTIOUS DISEASES, 2017, 17
  • [49] The Swiss Network of Dermatology Policlinics HIV prevalence study: Rationale, characteristics and results (1990-1996)
    Paget, WJ
    Batter, V
    Zwahlen, M
    SOZIAL-UND PRAVENTIVMEDIZIN, 1999, 44 (01): : 1 - 7
  • [50] Cohort Profile Update: The Swiss HIV Cohort Study (SHCS)
    Scherrer, Alexandra U.
    Traytel, Anna
    Braun, Dominique L.
    Calmy, Alexandra
    Battegay, Manuel
    Cavassini, Matthias
    Furrer, Hansjakob
    Schmid, Patrick
    Bernasconi, Enos
    Stoeckle, Marcel
    Kahlert, Christian
    Trkola, Alexandra
    Kouyos, Roger D.
    Tarr, Philip
    Marzolini, Catia
    Wandeler, Gilles
    Fellay, Jacques
    Bucher, Heiner
    Yerly, Sabine
    Suter, Franziska
    Hirsch, Hans
    Huber, Michael
    Dollenmaier, Gunter
    Perreau, Matthieu
    Martinetti, Gladys
    Rauch, Andri
    Guenthard, Huldrych F.
    INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2022, 51 (01) : 33 - +